Free Trial

Eledon Pharmaceuticals (ELDN) Insider Trading & Ownership

Eledon Pharmaceuticals logo
$5.30
+0.65 (+13.98%)
(As of 11/1/2024 ET)

Eledon Pharmaceuticals (NASDAQ:ELDN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.70%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$8,960.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get ELDN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ELDN Insider Buying and Selling by Quarter

Eledon Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/20/2021David-Alexandre C GrosCEOBuy2,000$4.48$8,960.00  
(Data available from 1/1/2013 forward)

ELDN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Eledon Pharmaceuticals includes David-Alexandre C Gros. Learn more on insiders at ELDN.

11.70% of Eledon Pharmaceuticals stock is owned by insiders. Learn more on ELDN's insider holdings.

Eledon Pharmaceuticals Key Executives

  • Dr. David-Alexandre C. Gros M.D.Dr. David-Alexandre C. Gros M.D. (Age 52)
    Ph.D., CEO & Non Independent Director
    Compensation: $807.96k
  • Dr. Steven N. Perrin Ph.D. (Age 58)
    President, Chief Scientific Officer & Non Independent Director
    Compensation: $603.9k
  • Mr. Paul Sean Little (Age 59)
    CFO & Principal Accounting Officer
    Compensation: $611.71k
  • Mr. John Herberger
    Vice President of Technical Operations
  • Mr. Bryan E. Smith J.D. (Age 44)
    General Counsel, Corporate Secretary & Chief Compliance Officer
    Compensation: $377.14k
  • Dr. David Hovland Ph.D.
    Chief Regulatory Officer
  • Dr. Eliezer Katz F.A.C.S.
    FACS, M.D., Chief Medical Officer


This page (NASDAQ:ELDN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners